Skip to main content

Cell Source, Inc.

Qualité des données : 83%
CLCS
OTC Manufacturing Chemicals
0,84 €
▲ 0,06 € (8,03%)
Cap. Boursière: 37,83 M
Prix
0,84 €
Cap. Boursière
37,83 M
Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Quick Summary

Points Clés

Negative free cash flow of -2,68 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-873,75%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

Valorisation

PE (TTM)
-8,38
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -8,4 -1,5
P/B 1,6
ROE % -54,0
Net Margin % -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4,51 M
ROE N/A ROA -1299,67%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -2,68 M
ROIC -873,75% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover N/A
Working Capital N/A Tangible Book Value -18,94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,38 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7,09%
Market Cap 37,83 M Enterprise Value 37,83 M
Per Share
EPS (Diluted TTM) -0,14 Revenue / Share N/A
FCF / Share -0,06 OCF / Share -0,06
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 59,48%
SBC-Adj. FCF -2,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue
Net Income -4,51 M -5,32 M -5,17 M -5,47 M -4,56 M
EPS (Diluted) -0,14 -0,17 -0,18
Gross Profit
Operating Income -3,84 M -4,33 M -4,18 M -4,02 M -3,64 M
EBITDA
R&D Expenses 1,94 M 1,27 M 834 943,0
SG&A Expenses
D&A
Interest Expense 629 201,0 457 371,0
Income Tax 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 286 500,0 195 171,0 409 845,0 313 767,0 452 339,0
Total Liabilities 18,82 M 15,81 M 13,04 M 8,40 M
Shareholders' Equity -18,54 M -15,61 M -12,63 M -9,83 M -7,95 M
Total Debt
Cash & Equivalents 222 665,0 93 095,0 245 119,0
Current Assets 313 767,0
Current Liabilities 10,14 M 8,40 M